YU26499A - Derivati diaza-spiro/3,5/nonana - Google Patents

Derivati diaza-spiro/3,5/nonana

Info

Publication number
YU26499A
YU26499A YU26499A YU26499A YU26499A YU 26499 A YU26499 A YU 26499A YU 26499 A YU26499 A YU 26499A YU 26499 A YU26499 A YU 26499A YU 26499 A YU26499 A YU 26499A
Authority
YU
Yugoslavia
Prior art keywords
hydrogen
lower alkyl
naphtalene
optionally substituted
ch2or5
Prior art date
Application number
YU26499A
Other languages
English (en)
Inventor
Geo Adam
Andrea Cesura
Francois Jenck
Sabine Kolczewski
Stephan Rover
Jurgen Wichmann
Original Assignee
F.Hoffmann-La Roche Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F.Hoffmann-La Roche Ag. filed Critical F.Hoffmann-La Roche Ag.
Publication of YU26499A publication Critical patent/YU26499A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

Ovaj pronalazak se odnosi na jedinjenja opste formule (I) u kojoj R1 je C6-C12-cikloalkil, proizvoljno supstituisan nizim alkilom ili C(O)O nizim alkilom, indan-1-il ili indan-2-il, proizvoljno supstituisan nizim alkilom; acenaften-1-il; biciklo[3.3.1] non-9-il, oktahidro-inden-2-il; 2,3-dihidro-1H-fenalen-1-il; 2,3,3a,4,5,6-heksahidro-1H-fenalen-1-il, dekahidro-azulen-2-il; biciklo[6.2.0] dek-9-il; dekahidronaftalen-1-il; dekahidro-naftalen-2-il; tetrahidro-naftalen-2-il, tetrahidro-naftalen-2-il ili 2-okso-1,2-difenil-etil; R2 je =O ili vodonik, R3 je vodonik, izoindolil-1,3-dion, nizi alkoksi, nizi alkil, amino, benziloksi, -CH2OR5 ili -CH2N(R5)2; R4 je vodonik ili -CH2OR5; R5 je vodonik ili nizi alkil; A je cikloheksil ili fenil, proizvoljno supstituisan nizim alkilom, halogenom ili alkoksijem, i na njihove farmaceutski prihvatljive kisele adicione soli. Jedinjenja ovog pronalaska su agonisti i/ili antagonisti orfamin FQ (OFQ) receptora i zato korisni u tretiranju bolesti, vezanih za ovaj receptor.
YU26499A 1998-06-12 1999-06-10 Derivati diaza-spiro/3,5/nonana YU26499A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98110804 1998-06-12

Publications (1)

Publication Number Publication Date
YU26499A true YU26499A (sh) 2002-09-19

Family

ID=8232114

Family Applications (1)

Application Number Title Priority Date Filing Date
YU26499A YU26499A (sh) 1998-06-12 1999-06-10 Derivati diaza-spiro/3,5/nonana

Country Status (28)

Country Link
US (1) US6113527A (sh)
EP (1) EP0970957B1 (sh)
JP (1) JP3286268B2 (sh)
KR (1) KR100344732B1 (sh)
CN (1) CN1107066C (sh)
AR (1) AR019859A1 (sh)
AT (1) ATE204279T1 (sh)
AU (1) AU743983B2 (sh)
BR (1) BR9902651A (sh)
CA (1) CA2274202A1 (sh)
DE (1) DE69900220T2 (sh)
DK (1) DK0970957T3 (sh)
ES (1) ES2162503T3 (sh)
HR (1) HRP990188A2 (sh)
HU (1) HU220894B1 (sh)
ID (1) ID23304A (sh)
IL (1) IL130377A0 (sh)
MA (1) MA26644A1 (sh)
NO (1) NO312590B1 (sh)
NZ (1) NZ336189A (sh)
PE (1) PE20000548A1 (sh)
PL (1) PL333695A1 (sh)
PT (1) PT970957E (sh)
SG (1) SG79259A1 (sh)
SI (1) SI0970957T1 (sh)
TR (1) TR199901381A3 (sh)
YU (1) YU26499A (sh)
ZA (1) ZA993852B (sh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030040479A1 (en) * 2001-07-02 2003-02-27 Omeros Corporation Rotational intrathecal analgesia method and device
CA2490386A1 (en) * 2001-07-02 2003-01-16 Omeros Corporation Method for producing analgesia comprising administration of an opioid receptor agonist in rotation with an opioid receptor like-1 receptor agonist
US7566728B2 (en) 2002-03-29 2009-07-28 Mitsubishi Tanabe Pharma Corporation Remedy for sleep disturbance
JP2005289816A (ja) 2002-05-14 2005-10-20 Banyu Pharmaceut Co Ltd ベンズイミダゾール誘導体
JP4749715B2 (ja) 2002-07-05 2011-08-17 ターガセプト，インコーポレイテッド Ｎ−アリールジアザスピロ環式化合物、並びにその製造及び使用方法
WO2004022558A2 (en) * 2002-09-09 2004-03-18 Janssen Pharmaceutica, N.V. Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1 receptor mediated disorders
GB0323204D0 (en) * 2003-10-03 2003-11-05 Novartis Ag Organic compounds
US20050228023A1 (en) * 2003-12-19 2005-10-13 Sri International Agonist and antagonist ligands of the nociceptin receptor
US20060178390A1 (en) * 2004-08-02 2006-08-10 Alfonzo Jordan 1,3,8-Triazaspiro[4,5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders
CN101022801A (zh) * 2004-08-20 2007-08-22 塔加西普特公司 N－芳基二氮杂螺环化合物在成瘾治疗中的用途
US20080247964A1 (en) * 2006-05-08 2008-10-09 Yuelian Xu Substituted azaspiro derivatives
WO2008067167A1 (en) * 2006-11-28 2008-06-05 Janssen Pharmaceutica N.V. Salts of 3-(3-amino-2-(r)-hydroxy-propyl)-1-(4-fluoro-phenyl)-8-(8-methyl-naphthalen-1-ylmethyl)-1,3,8-triaza-spiro[4.5]decan-4-one
CN101679430B (zh) * 2007-04-09 2013-12-25 詹森药业有限公司 用于治疗焦虑和抑郁症的作为orl-1受体的配体的1,3,8-三取代-1,3,8-三氮杂-螺[4.5]癸-4-酮衍生物
KR101704226B1 (ko) 2015-06-30 2017-02-07 현대자동차주식회사 자동차의 쿼터글라스 어셈블리
TW202340202A (zh) * 2021-12-22 2023-10-16 美國加利福尼亞大學董事會 Gtp酶抑制劑及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756743A (en) * 1996-04-10 1998-05-26 Hoechst Marion Roussel Inc. Spiro cyclopent b!indole-piperidines!

Also Published As

Publication number Publication date
AR019859A1 (es) 2002-03-20
JP2000053679A (ja) 2000-02-22
ID23304A (id) 2000-04-05
EP0970957A1 (en) 2000-01-12
IL130377A0 (en) 2000-06-01
AU3498799A (en) 1999-12-23
ES2162503T3 (es) 2001-12-16
NZ336189A (en) 2000-10-27
SI0970957T1 (sh) 2001-12-31
TR199901381A2 (xx) 2000-01-21
SG79259A1 (en) 2001-03-20
CA2274202A1 (en) 1999-12-12
TR199901381A3 (tr) 2000-01-21
KR20000006060A (ko) 2000-01-25
ATE204279T1 (de) 2001-09-15
PT970957E (pt) 2002-02-28
BR9902651A (pt) 2000-05-16
DE69900220T2 (de) 2002-05-08
NO992873L (no) 1999-12-13
HRP990188A2 (en) 2000-02-29
NO312590B1 (no) 2002-06-03
KR100344732B1 (ko) 2002-07-19
ZA993852B (en) 1999-12-13
MA26644A1 (fr) 2004-12-20
DK0970957T3 (da) 2001-12-03
HU220894B1 (en) 2002-06-29
US6113527A (en) 2000-09-05
CN1242366A (zh) 2000-01-26
PE20000548A1 (es) 2000-07-15
DE69900220D1 (de) 2001-09-20
NO992873D0 (no) 1999-06-11
PL333695A1 (en) 1999-12-20
JP3286268B2 (ja) 2002-05-27
AU743983B2 (en) 2002-02-14
EP0970957B1 (en) 2001-08-16
HU9901911D0 (en) 1999-08-30
HUP9901911A1 (hu) 2000-05-28
CN1107066C (zh) 2003-04-30

Similar Documents

Publication Publication Date Title
YU26499A (sh) Derivati diaza-spiro/3,5/nonana
US5958931A (en) Phenyl-substituted 5H-thiazolo 3,2-A!pyrimidine derivative glutamate receptor antagonists
MX9709951A (es) Derivados de benzamida y su uso como antagonistas de vasopresina.
BG103785A (en) Pyrrolo[2,3-d]pyrimidines and their application as tyrosine kinase inhibitors
EP1465631A4 (en) A2B RECEPTOR-BASED ANTAGONIST PYRIMIDINE COMPOUNDS, THEIR SYNTHESIS AND USE THEREOF
EP0445811A3 (en) Nitrogen-containing heterocyclic compounds, their production and use
DE60329513D1 (de) Antagonist des melanin-concentrating-hormone-rezeptors, enthaltend ein benzimidazolderivat als wirkstoff
MX2007004250A (es) Derivados de imidazo[1,5-a]triazolo[1,5-d]benzodiazepina para el tratamiento de trastornos cognitivos.
TW200504085A (en) Derivatives of [2-(8,9-dioxo-2, 6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl]phosphonic acid and methods of use thereof
TW377352B (en) Pyrido[2,3-d]pyrimidine derivatives and pharmaceutical compositions thereof
MXPA02004448A (es) Derivados de imidazopiridina como inhibidores de la fosfodiesterasa vii.
CA2244777A1 (en) 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors
DE69401716D1 (de) Imidazo [1,2-a] pyrasin-4-on-derivate welche als ampa und nmda receptor antagonisten dienen
ES2000935A6 (es) Un procedimiento para la preparacion de 3-imidazolin-metiltetrahidrocarbazolonas.
EP0997462A4 (en) NOVEL NAPHTHYRIDINE DERIVATIVES OR THEIR SALTS
CA2134077A1 (en) 4-imidomethyl-1-[2'phenyl-2'oxoethyl-]piperidines as serotonin 5ht2-antagonists, their preparation and use in therapy
CA2375671A1 (en) 4-phenyl-pyrimidine derivatives
GB9011469D0 (en) Chemical process
CA2194877A1 (en) Heterocycle-condensed morphinoid derivatives
JO2307B1 (en) Papermidine derivatives
MXPA04003278A (es) Derivados de 5-metoxi-8-aril-?1,2,4?triazolo?1,5-a?piridina como antagonistas del receptor de adenosina.
PE20000540A1 (es) Derivados de diaza-espiro [4.5]decan
ATE325790T1 (de) Harnstoff-verbindungen, ein verfahren zu deren herstellung und ihre verwendung
AP9801410A0 (en) Indoline derivatives useful as 5-HT-2C receptor antagonists.
GB9720270D0 (en) Medicaments for the treatment of migraine